The following  presentation topic will be presented at the Hematologic Malignancy Grand Rounds Conference on Friday, December 13, 2013  from 9:15 a.m. - 10:15 a.m. in M224 Markee Classroom, Second Floor, Green Zone, Duke South Clinic's Davison Building.

" Treatment of Older Patients with High Risk Myelodysplastic Syndrome:  

A New Clinical Trial Option"


by  Mitchell Horwitz, MD



Disclosure:  Mitchell Horwitz, MD - Consultant for Gamida cell, PI for Sanofi-Aventis, and Advisory Board Member for Spectrum.

Davison Building
Duke South Clinics Green Zone
2nd Floor, M224 Markee Classroom
Durham, NC 27710
United States
Session date: 
12/13/2013 - 9:15am to 10:15am EST

Please login or register to take this course.
Room Number: 
Speaker Name: 
Mitchell Horwitz, MD